tiprankstipranks
Trending News
More News >
Cytori Cell Research Institute, Inc. (JP:3750)
:3750
Japanese Market
Advertisement

Cytori Cell Research Institute, Inc. (3750) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Cytori Cell Research Institute, Inc. has a market cap or net worth of ¥8.21B. The enterprise value is ¥9.55B.
Market Cap¥8.21B
Enterprise Value¥9.55B

Share Statistics

Cytori Cell Research Institute, Inc. has 8,929,419 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,929,419
Owned by Insiders
Owned by Institutions

Financial Efficiency

Cytori Cell Research Institute, Inc.’s return on equity (ROE) is -3.39 and return on invested capital (ROIC) is -23.59%.
Return on Equity (ROE)-3.39
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-23.59%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee7.64M
Profits Per Employee-133.76M
Employee Count16
Asset Turnover0.03
Inventory Turnover3.97

Valuation Ratios

The current PE Ratio of Cytori Cell Research Institute, Inc. is 55.1. Cytori Cell Research Institute, Inc.’s PEG ratio is ―.
PE Ratio55.1
PS Ratio0.00
PB Ratio0.00
Price to Fair Value11.36
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio

Income Statement

In the last 12 months, Cytori Cell Research Institute, Inc. had revenue of 122.20M and earned -2.14B in profits. Earnings per share was -239.70.
Revenue122.20M
Gross Profit-55.56M
Operating Income-806.89M
Pretax Income-2.15B
Net Income-2.14B
EBITDA-2.02B
Earnings Per Share (EPS)-239.70

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Cytori Cell Research Institute, Inc. pays an annual dividend of ¥10, resulting in a dividend yield of ―
Dividend Per Share¥10
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.47
52-Week Price Change0.22%
50-Day Moving Average812.32
200-Day Moving Average827.76
Relative Strength Index (RSI)64.77
Average Volume (3m)16.57K

Important Dates

Cytori Cell Research Institute, Inc. upcoming earnings date is Aug 14, 2025, TBA (Confirmed).
Last Earnings DateMay 15, 2025
Next Earnings DateAug 14, 2025
Ex-Dividend DateMar 30, 2020

Financial Position

Cytori Cell Research Institute, Inc. as a current ratio of 1.05, with Debt / Equity ratio of 420.00%
Current Ratio1.05
Quick Ratio0.96
Debt to Market Cap0.37
Net Debt to EBITDA-1.18
Interest Coverage Ratio-9.84

Taxes

In the past 12 months, Cytori Cell Research Institute, Inc. has paid -12.50M in taxes.
Income Tax-12.50M
Effective Tax Rate<0.01

Enterprise Valuation

Cytori Cell Research Institute, Inc. EV to EBITDA ratio is -4.73, with an EV/FCF ratio of -9.60.
EV to Sales78.17
EV to EBITDA-4.73
EV to Free Cash Flow-9.60
EV to Operating Cash Flow-9.68

Balance Sheet

Cytori Cell Research Institute, Inc. has ¥443.00M in cash and marketable securities with ¥2.66B in debt, giving a net cash position of ¥2.22B billion.
Cash & Marketable Securities¥443.00M
Total Debt¥2.66B
Net Cash¥2.22B
Net Cash Per Share¥248.28
Tangible Book Value Per Share¥70.62

Margins

Gross margin is -13.26%, with operating margin of -660.28%, and net profit margin of -1751.24%.
Gross Margin-13.26%
Operating Margin-660.28%
Pretax Margin-1761.64%
Net Profit Margin-1751.24%
EBITDA Margin-1653.95%
EBIT Margin-1694.52%

Analyst Forecast

The average price target for Cytori Cell Research Institute, Inc. is ¥683.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target¥683.00
Price Target Upside-25.68% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-92.17%
EPS Growth Forecast-1648.96%

Scores

Smart ScoreN/A
AI Score54
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis